MICHAEL D. WORTLEY - 03 Jan 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role
Chief Legal Officer
Signature
/s/ Tracy Herson, attorney-in-fact
Issuer symbol
RETA
Transactions as of
03 Jan 2023
Transactions value $
$0
Form type
4
Filing time
04 Jan 2023, 16:12:03 UTC
Previous filing
05 Jan 2022
Next filing
06 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RETA Class A common stock Award $0 +15,675 +44.8% $0.000000 50,675 03 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RETA Employee Stock Option (right-to-buy) Award $0 +63,650 $0.000000 63,650 03 Jan 2023 Class A common stock 63,650 $36.71 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares represent Restricted Stock Units, which vest 1/16th of each grant on March 6, May 15, August 15, and November 15 of each year, subject to continued service through each vesting date.
F2 The options vest 1/16th of each grant on March 6, May 15, August 15, and November 15 of each year, subject to continued service through each vesting date.